Yahoo Web Search

Sign In

Search results

  1. People also ask

  2. www.clearmindbiomedicalgroup.comClearpath | ClearMind Biomedical Inc. | United States

    Brain hemorrhage, or hemorrhagic stroke, is the dealiest form of all stroke with the death rate as high as 36-60%. Only less than 20% of these patient can take care of themselves 3 months after the event. Each year, more than 4,600,000 patients received traditional brain surgery for this disease despite the known poor surgical outcome. We can ...

    • ABOUT

      That's why we want to make it a device - a device as...

    • PRODUCT

      Clearmind Biomedical create micro-invasive technology,...

    • MEDIA PRESS

      The ClearMind vision is to save lives and help patients...

    • CONTACT

      ClearMind Biomedical Inc. + 886 2-22697417....

    • History

      • 510(K) cleared for Axonpen System • Start FIM clinical...

    • Team

      BIOMEDICAL. HOME. ABOUT. History; Team; PRODUCT. Axonpen...

    • Neuroblade System

      2% Rebleeding. Clearmind Biomedical create micro-invasive...

  3. www.linkedin.com › company › clearmind-biomedical-incClearmind Biomedical Inc. | LinkedIn

    Clearmind Biomedical Inc. | 124 followers on LinkedIn. Providing innovative technologies in neurosurgical field | Established in 2014, ClearMind was created with backing from Y Combinator, one of ...

  4. www.biospace.com › article › releasesClearMind Biomedical Clears FIM Clinical Trial for Least ...

    Jul 6, 2022 · Presently, ClearMind Biomedical's second trial for the Axonpen System is underway in Taiwan and the company is looking to conduct its next trial in the US. The Axonpen System is the most integrated minimally invasive neurosurgical tool, combining over eight key features including tissue visualization, a debrider and a flexible tip.

  5. www.crunchbase.com › organization › clearmind-biomedicalClearmind Biomedical - Crunchbase Company Profile & Funding

    Clearmind Biomedical may be growing as the company operates in the neuroendoscopy devices industry, which is reported to experience a significant compound annual growth rate (CAGR) of 4.9%. This industry growth suggests a favorable market environment for Clearmind Biomedical's products.

  6. www.biospace.com › article › releasesClearMind Biomedical's Axonpen Neuroendoscope ... - BioSpace

    Jan 11, 2021 · ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance. LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received FDA clearance for its novel neuroendoscope, the Axonpen System, for illumination and visualization of intracranial tissue and fluids, and the controlled aspiration of tissue and/or fluid during ...

  1. Searches related to clearmind biomedical

    clearmind biomedical taiwan